The use of enzyme results for liver fibrosis evaluation neccessitates standardization.

Myara A, Guechot J, Lasnier E, Imbert-Bismut F, Voitot H …

MeSH — NLM indexing Alanine Transaminase / blood Alanine Transaminase / standards Aspartate Aminotransferases / blood Aspartate Aminotransferases / standards Biomarkers / blood Humans Liver Cirrhosis / diagnosis

Staff actions

Download PDF

Files are for authorised use within BioPredictive partner channels only.

Fibrotest Actitest Letter Our Group France

Authors (6)

Citation

Myara A, Guechot J, Lasnier E, Imbert-Bismut F, Voitot H, Ferard G. The use of enzyme results for liver fibrosis evaluation neccessitates standardization. Hepatology. 2008;47(3):1100-1. doi:10.1002/hep.22128.

Identifiers

DOI: 10.1002/hep.22128
PMID: 18266251

Tests

Liver diseases

Liver injuries

Comparisons

Subjects

Region

The use of enzyme results for liver fibrosis evaluation neccessitates standardization.

More on the same topic

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Toward non-invasive assessment strategies in autoimmune hepatitis.

Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.

Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease.